Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors.
Weatherald J, Bondeelle L, Chaumais MC, Guignabert C, Savale L, Jaïs X, Sitbon O, Rousselot P, Humbert M, Bergeron A, Montani D.
Weatherald J, et al. Among authors: jais x.
Eur Respir J. 2020 Oct 29;56(4):2000279. doi: 10.1183/13993003.00279-2020. Print 2020 Oct.
Eur Respir J. 2020.
PMID: 32527740
Free article.
Review.